Xlife Sciences AG (XSWX:XLS) OCF Margin %: 125.32% (As of Dec. 2025)


XSWX:XLS Xlife Sciences AG XSWX:XLS
50 GF Score
Price CHF20.90
GF Value CHF7.30
Valuation Significantly Overvalued
! 13 Warning Signs
View Full Analysis

What is Xlife Sciences AG OCF Margin %?

Xlife Sciences AG XSWX:XLS -11.06% 50 OCF Margin % is 125.32% as of Dec. 2025. GuruFocus rates XSWX:XLS with a GF Score™ of 50/100 and a GF Value™ of CHF7.30 (Significantly Overvalued). The stock has 13 warning signs investors should review. Among 960 Biotechnology companies, Xlife Sciences AG ranks worse than 66.98% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Xlife Sciences AG's Cash Flow from Operations for the six months ended in Dec. 2025 was CHF-0.10 Mil. Xlife Sciences AG's Revenue for the six months ended in Dec. 2025 was CHF-0.08 Mil. Therefore, Xlife Sciences AG's OCF Margin % for the quarter that ended in Dec. 2025 was 125.32%.

As of today, Xlife Sciences AG's current OCF Yield % is -0.62%.

The historical rank and industry rank for Xlife Sciences AG's OCF Margin % or its related term are showing as below:

XSWX:XLS' s OCF Margin % Range Over the Past 10 Years
Min: -536.48   Med: -101.26   Max: 17.41
Current: -328.36

During the past 8 years, the highest OCF Margin % of Xlife Sciences AG was 17.41%. The lowest was -536.48%. And the median was -101.26%.

XSWX:XLS's OCF Margin % is ranked worse than
66.98% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs XSWX:XLS: -328.36

Xlife Sciences AG OCF Margin % Related Terms

Xlife Sciences AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for Xlife Sciences AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xlife Sciences AG OCF Margin % Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -536.48 -448.15 17.41 -50.54 -328.36

Xlife Sciences AG Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 454.84 -285.14 118.76 -227.12 125.32

XSWX:XLS vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Xlife Sciences AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xlife Sciences AG OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's OCF Margin % falls into.


XSWX:XLS
50GF Score
Xlife Sciences AG XSWX:XLS
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xlife Sciences AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Xlife Sciences AG's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.903/0.275
=-328.36 %

Xlife Sciences AG's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.099/-0.079
=125.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 125.32% mean?
Xlife Sciences AG (XSWX:XLS) has a OCF Margin % of 125.32% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xlife Sciences AG and its competitors. According to the industry distribution chart, Xlife Sciences AG ranks #643 out of 960 companies in the Biotechnology industry, placing it in the top 67%.
Is Xlife Sciences AG's OCF Margin % too high?
Xlife Sciences AG's current OCF Margin % is 125.32%. Based on the distribution chart, Xlife Sciences AG ranks #643 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Xlife Sciences AG has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xlife Sciences AG's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xlife Sciences AG ranks #643 out of 960 companies for OCF Margin %. This places Xlife Sciences AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xlife Sciences AG and its competitors. Xlife Sciences AG's current OCF Margin % is 125.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xlife Sciences AG stock overvalued right now?
Based on GuruFocus' analysis, Xlife Sciences AG (XSWX:XLS) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF7.30, compared to a current price of CHF20.90 — trading 186.3% above its estimated fair value. The current OCF Margin % is 125.32%. Xlife Sciences AG's overall GF Score™ is 50/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Xlife Sciences AG (XSWX:XLS), the current OCF Margin % is 125.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xlife Sciences AG (XSWX:XLS) Overvalued in 2026?

Based on GuruFocus' analysis, Xlife Sciences AG stock appears to be overvalued. The current stock price of CHF20.90 is trading 186.3% above its estimated GF Value™ of CHF7.30. GuruFocus considers Xlife Sciences AG to be Significantly Overvalued.

Key valuation signals for XSWX:XLS:

  • OCF Margin %: 125.32%
  • GF Value™: CHF7.30 vs. price of CHF20.90 (186.3% above fair value)
  • GF Score™: 50/100 with 13 warning signs

No single metric tells the full story. See the XSWX:XLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xlife Sciences AG Business Description

Other Exchanges XLSz:UKXLS:Germany
Address Talacker 35, Zurich, CHE, 8001
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high-unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments, which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial Intelligence/Digital Medicine.
50GF Score

Get the complete analysis for XSWX:XLS

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF20.90
Price
CHF7.30
GF Value